Advertisement

Research Article Free access | 10.1172/JCI110474

Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.

W F Stenson and E Lobos

Find articles by Stenson, W. in: PubMed | Google Scholar

Find articles by Lobos, E. in: PubMed | Google Scholar

Published February 1, 1982 - More info

Published in Volume 69, Issue 2 on February 1, 1982
J Clin Invest. 1982;69(2):494–497. https://doi.org/10.1172/JCI110474.
© 1982 The American Society for Clinical Investigation
Published February 1, 1982 - Version history
View PDF
Abstract

Neutrophils metabolize arachidonic acid through the liposygenase pathway to 5-hydroxy-6,8,11,14-eicosatetrenoic acid (5-HETE) and 5,12-dihydroxy-6,8,10,14-eicosatraenoic acid (5,12 diHETE). 5-HETE and 5,12diHETE are potent chemotactic agents and are thought to have important roles in the inflammatory response. In this study we demonstrate the sulfasalazine, at concentrations found in the stool of patients being treated for ulcerative colitis, blocks the synthesis of both 5-HETE and 5,12 diHETE by human neutrophils. A sulfasalazine metabolite, 5-aminosalicylate, also blocks the synthesis of 5,12 diHETE.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (February 1, 1982): No description
Advertisement
Advertisement